NATHBIOGEN

Nath Bio-Genes (India) Ltd

₹187.95

Nath Bio-Genes (India) Ltd Results Summary

Revenue	₹45.24Cr
Net Profits	₹1.45Cr
Net Profit Margins	3.21%

Highlights

Revenue:

Nath Bio-Genes (India) Ltd’s revenue jumped 61.92% since last year same period to ₹45.24Cr in the Q4 2022-2023. On a quarterly growth basis, Nath Bio-Genes (India) Ltd has generated 78.39% jump in its revenue since last 3-months.

Net Profits:

Nath Bio-Genes (India) Ltd’s net profit jumped 101.25% since last year same period to ₹1.45Cr in the Q4 2022-2023. On a quarterly growth basis, Nath Bio-Genes (India) Ltd has generated 7.41% jump in its net profits since last 3-months.

Net Profit Margins:

Nath Bio-Genes (India) Ltd’s net profit margin jumped 100.77% since last year same period to 3.21% in the Q4 2022-2023. On a quarterly growth basis, Nath Bio-Genes (India) Ltd has generated -39.79% fall in its net profit margins since last 3-months.

Key Ratios

Key ratios of the Nath Bio-Genes (India) Ltd post its Q4 2022-2023 results

Return on Equity (ROE)	22.77
Dividend Per Share (DPS)	2

Highlights

Return On Equity (ROE):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Nath Bio-Genes (India) Ltd’s return on equity (ROE) stands at 22.77.

Dividend Per Share (DPS):

Nath Bio-Genes (India) Ltd declared 2 dividend per share during the results announcement for Q1 2023-2024.